Watch Ticker

Adial Pharmaceuticals, Inc

Go to Adial Pharmaceuticals, Inc Website

$0.40

-0.05 (-11.60%)

Live

Previous Close

$0.4154

Day Range

$0.4 - $0.435

Previous Day Range

$0.389 - $0.48

Market Cap

$7.2 million USD

Day Vol.

1.3 million

Previous Day Vol.

2.1 million

Currency

USD

Primary Exchange

Nasdaq

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingre...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight

The substance use disorder market is expected to grow between 2025 and 2034, driven by greater awareness, the introduction of new therapies, and ongoing research and development efforts. The report covers the market assessment of Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder.

Related tickers: ADIL, CMND, BTAI, INDV.

Read Full Article

N/A - Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Adial Pharmaceuticals received positive feedback from the FDA on its proposed in vitro bridging strategy for its drug candidate AD04, a key step towards advancing the drug into Phase 3 clinical trials for the treatment of alcohol use disorder.

Related tickers: ADIL.

Read Full Article

Trending Tickers

Please sign in to view